Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.

Viatris

Status and phase: Completed; Phase 4

Conditions: Urinary Incontinence

Treatments: Drug: Tolterodine ER 4 mg QD; Behavioral: OAB Patient Behavioral Training Material

Study type: Interventional

Funder types: Industry

Identifiers

NCT00230789

A6121146

Details and patient eligibility

About

To evaluate the effect of tolterodine ER in conjunction with behavioral intervention on subject satisfaction in OAB subjects who were dissatisfied with their most recent antimuscarinic OAB medication therapy.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female subjects greater than or equal to 18 years of age
• Overactive bladder symptoms for at least 3 months
• Previously treated with antimuscarinic OAB medications

Exclusion criteria

• Participation in any professionally coached sessions (RN, NP, PA or PT) teaching behavioral interventions

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)